VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

JPMORGAN CHASE & CO's Holding History (CIK: 0000019617)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 1,141,911 Value ($000) $12,824 Avg Close — Range —
Q1 2025
Shares 316,179 Value ($000) $1,445 Avg Close — Range —
Q4 2024
Shares 417,539 Value ($000) $2,355 Avg Close — Range —
Q3 2024
Shares 1,647,844 Value ($000) $7,976 Avg Close — Range —
Q2 2024
Shares 1,691,352 Value ($000) $8,254 Avg Close — Range —
Q1 2024
Shares 1,493,050 Value ($000) $19,828 Avg Close — Range —
Q4 2023
Shares 2,058,399 Value ($000) $28,694 Avg Close — Range —
Q3 2023
Shares 2,505,896 Value ($000) $33,228 Avg Close — Range —
Q2 2023
Shares 1,838,986 Value ($000) $34,481 Avg Close — Range —
Q1 2023
Shares 1,908,364 Value ($000) $27,518 Avg Close — Range —
Q4 2022
Shares 1,788,462 Value ($000) $35 Avg Close — Range —
Q3 2022
Shares 1,918,490 Value ($000) $65,901 Avg Close — Range —
Q2 2022
Shares 1,354,638 Value ($000) $20,699 Avg Close — Range —
Q1 2022
Shares 1,118,834 Value ($000) $25,532 Avg Close — Range —
Q4 2021
Shares 877,298 Value ($000) $32,345 Avg Close — Range —
Q3 2021
Shares 899,865 Value ($000) $42,294 Avg Close — Range —
Q2 2021
Shares 920,252 Value ($000) $55,446 Avg Close — Range —